Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

SUNSHINE PHARMA(06887.HK)

Event Tracking

Apr8

Insulin Sodium Injection for Vonoprazan Application for Market Approval Accepted by China's NMPA

09:46

Apr1

East Sun 药业 2025 Annual Report Reveals Revenue Growth and Profit Turnaround

12:37

Mar24

SUNSHINE PHARMA to release FY2025 annual earnings report on March 31, 2026 during market hours (BJT), forecast revenue HKD 4.625 B

00:09

Jan26

East Sun Pharma Partners with Shenzhen XtalTech to Build AI-Driven Drug Development Platform

11:13

Jan16

East Sun Pharm's Alogetagliptin Capsules Approved for Market Launch

11:41

Jan5

East Sun Pharm 斥资 3.8983 百万港元回购 88,800 股

12:39

Schedules & Filings

Schedules

Filings

Mar31

Earning Release(CST)

FY2025 Annual Earning Release

Apr28

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 675.03 M, Net Income -107.46 M, EPS -0.4641

Sep30

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 1.319 B, Net Income 367.88 M, EPS 1.5858

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

SUNSHINE PHARMA(06887.HK)

SUNSHINE PHARMA Stock Performance Chart